COVID-19 Vaccine Uptake and Socioeconomic Disparities in Tanzania: A Population-Based Cross-Sectional Study Amid High Hesitancy.

Publication date: Jul 01, 2025

Socioeconomic disparities in healthcare access, including vaccination services, persist worldwide. The COVID-19 pandemic amplified these disparities, particularly in low-resource settings such as Tanzania, where vaccine hesitancy remains a significant challenge. Understanding these disparities is crucial for achieving equitable vaccine coverage. This study assessed regional variations in socioeconomic disparities in COVID-19 vaccine uptake in Tanzania, with education used as a proxy for socioeconomic status. The findings aim to guide targeted interventions for populations facing greater disadvantages. A population-based cross-sectional survey was conducted between June and July 2022, involving 22,910 adults from urban areas in Mwanza, Iringa, Arusha, and Morogoro regions. Participants were selected using cluster sampling. Vaccine uptake, defined as receiving any complete dose of the COVID-19 vaccine, was the primary outcome. Disparities were analyzed using concentration curves and indices, while multivariable logistic regression identified factors contributing to these disparities. Of the respondents, approximately 20% were fully vaccinated. Significant educational disparities favoring the educated were observed, with the most pronounced gaps in Mwanza (CI: 0. 093, p 

Open Access PDF

Concepts Keywords
June COVID‐19 vaccine
Pandemic education
Socioeconomic regional disparities
Vaccine socioeconomic disparities
Tanzania
vaccine hesitancy

Semantics

Type Source Name
disease MESH COVID-19 pandemic
drug DRUGBANK Coenzyme M
disease MESH marital status
disease MESH education levels
pathway REACTOME Reproduction
disease MESH Emerging infectious diseases
disease MESH infectious diseases
drug DRUGBANK Tropicamide
disease MESH chronic illness
disease MESH asymptomatic infections
drug DRUGBANK Ademetionine
pathway REACTOME Translation
disease IDO quality
disease IDO site
drug DRUGBANK Trestolone
drug DRUGBANK Aspartame
disease MESH privacy
disease MESH hypertension
disease IDO country
drug DRUGBANK Serine
disease MESH diabetes mellitus
drug DRUGBANK Flunarizine
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH Morbidity
disease MESH Causes
drug DRUGBANK Phenylpropanolamine

Original Article

(Visited 6 times, 1 visits today)